Enhanced Positron Imaging Tomography for Bacterial Infection Diagnosis

Publication ID: 24-11857352_0006_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Positron Imaging Tomography for Bacterial Infection Diagnosis,” Published Technical Disclosure No. 24-11857352_0006_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857352_0006_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,352.

Summary of the Inventive Concept

A novel system and method for positron imaging tomography that improves the diagnosis of bacterial infections by enhancing radiochemical purity, dynamic ratio adjustment, and image resolution.

Background and Problem Solved

The original patent for positron imaging tomography imaging agent composition and method for bacterial infection has limitations in terms of radiochemical purity, ratio control, and image resolution. The new inventive concept addresses these limitations by introducing a novel injector module, dynamic ratio adjustment, and enhanced detector module, thereby providing a more efficient and accurate diagnosis of bacterial infections.

Detailed Description of the Inventive Concept

The new inventive concept comprises a novel injector module that incorporates a multi-step purification process to remove impurities and increase the yield of the radiolabeled compound. Additionally, the system includes a method for dynamically adjusting the ratio of 4-amino-2-[18F]-fluorobenzoic acid to 4-amino-2-[19F]-fluorobenzoic acid in real-time during the imaging process. Furthermore, the positron imaging tomography apparatus features an enhanced detector module with a proprietary algorithm for improved image resolution and reduced artifacts. The composition also includes a novel stabilizer that maintains the radiochemical purity of the radiolabeled compounds.

Novelty and Inventive Step

The new inventive concept is novel and non-obvious compared to the original patent due to the introduction of the novel injector module, dynamic ratio adjustment, and enhanced detector module. These features provide a significant improvement in radiochemical purity, ratio control, and image resolution, thereby enhancing the accuracy and efficiency of bacterial infection diagnosis.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include variations in the injector module design, such as using different purification methods or materials. Additionally, the dynamic ratio adjustment could be implemented using different algorithms or control systems. The enhanced detector module could also be modified to accommodate different imaging modalities or applications.

Potential Commercial Applications and Market

The new inventive concept has significant commercial potential in the medical imaging industry, particularly in the diagnosis and treatment of bacterial infections. The target market includes hospitals, research institutions, and pharmaceutical companies involved in the development of positron imaging tomography agents and imaging systems.

CPC Classifications

SectionClassGroup
A A61 A61B6/037
A A61 A61K51/0402
A A61 A61P31/04
C C07 C07B59/001
C C07 C07C227/12
C C07 C07C229/60

Field of Art

Medical imaging and radiopharmaceutical composition, specifically positron emission tomography (PET) for bacterial infection detection, involving radiochemical synthesis, imaging techniques, and molecular diagnostics

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in radiochemistry, nuclear medicine, or biomedical engineering, possessing expertise in radiolabeled compound preparation, imaging system design, and diagnostic imaging optimization

Obviousness Rationale

A person having ordinary skill in the art would recognize that the published technical disclosure represents predictable variations and incremental improvements to the source patent's core technology. The proposed enhancements in injector module design, ratio adjustment, and detector sensitivity represent standard engineering approaches to refining diagnostic imaging systems. These modifications would be considered routine optimization techniques within the established technological framework of positron imaging tomography.

Obvious Combinations & Variations

Source Patent Element
Composition with specific ratios of 4-amino-2-[18F]-fluorobenzoic acid to 4-amino-2-[19F]-fluorobenzoic acid
PTD Variation
Dynamic real-time ratio adjustment during imaging process
Obviousness Reasoning
A PHOSITA would recognize that implementing dynamic ratio control is a predictable solution for improving diagnostic accuracy, utilizing standard control system engineering principles
Source Patent Element
Radiochemical composition for bacterial infection imaging
PTD Variation
Multi-step purification process in injector module to increase radiolabeled compound yield
Obviousness Reasoning
Purification technique represents a known method for improving radiochemical purity, utilizing standard separation and concentration techniques familiar to radiochemistry practitioners
Source Patent Element
Basic PET imaging methodology for detecting bacterial infections
PTD Variation
Enhanced detector module with proprietary algorithm for improved image resolution
Obviousness Reasoning
Algorithmic image enhancement represents a standard approach to improving diagnostic imaging, utilizing well-established signal processing and computational techniques
Source Patent Element
Radiolabeled compound composition
PTD Variation
Novel stabilizer preventing compound degradation
Obviousness Reasoning
Developing stabilization techniques for radiochemical compounds is a predictable solution using known antioxidant and preservation strategies in pharmaceutical chemistry
Source Patent Element
Fixed ratio ranges for radiolabeled compounds
PTD Variation
Machine learning algorithm for optimizing compound ratios based on patient-specific factors
Obviousness Reasoning
Implementing adaptive optimization through machine learning represents a standard engineering approach to improving diagnostic precision using computational techniques
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857352 and the published technical disclosure, a person having ordinary skill in the art would find the claimed variations obvious and anticipated, as the proposed modifications represent predictable engineering solutions within the established technological framework of positron imaging tomography for bacterial infection diagnosis. The incremental improvements in imaging system design, compound preparation, and diagnostic optimization would be considered routine modifications by a skilled practitioner in the field.

Original Patent Information

Patent NumberUS 11,857,352
TitlePositron imaging tomography imaging agent composition and method for bacterial infection
Assignee(s)The Research Foundation for The State of University New York